Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Northwest Biotherapeutics's total assets was $75.94M at Jun 30, 2026. For fiscal 2025 it was $81.29M, up 204.1% from the year before. Over ten years it grew 1.4% a year on average. The highest annual figure on record is $81.29M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.29M | +204.1% |
| FY2024 | Dec 31, 2024 | $26.73M | -4.1% |
| FY2023 | Dec 31, 2023 | $27.87M | -11.0% |
| FY2022 | Dec 31, 2022 | $31.32M | -22.0% |
| FY2021 | Dec 31, 2021 | $40.16M | +22.1% |
| FY2020 | Dec 31, 2020 | $32.90M | +209.1% |
| FY2019 | Dec 31, 2019 | $10.64M | -56.9% |
| FY2018 | Dec 31, 2018 | $24.67M | -49.6% |
| FY2017 | Dec 31, 2017 | $48.91M | -7.6% |
| FY2016 | Dec 31, 2016 | $52.91M | -25.3% |
| FY2015 | Dec 31, 2015 | $70.80M | +25.4% |
| FY2014 | Dec 31, 2014 | $56.46M | +200.6% |
| FY2013 | Dec 31, 2013 | $18.78M | +148.1% |
| FY2012 | Dec 31, 2012 | $7.57M | +3470.8% |
| FY2011 | Dec 31, 2011 | $212.00K | -27.9% |
| FY2010 | Dec 31, 2010 | $294.00K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $75.94M | +157.0% |
| Q1 FY2026 | Mar 31, 2026 | $80.05M | +191.0% |
| Q4 FY2025 | Dec 31, 2025 | $81.29M | +204.1% |
| Q3 FY2025 | Sep 30, 2025 | $30.61M | +4.4% |
| Q2 FY2025 | Jun 30, 2025 | $29.55M | +4.7% |
| Q1 FY2025 | Mar 31, 2025 | $27.51M | -3.7% |
| Q4 FY2024 | Dec 31, 2024 | $26.73M | -4.1% |
| Q3 FY2024 | Sep 30, 2024 | $29.32M | -6.9% |
| Q2 FY2024 | Jun 30, 2024 | $28.23M | -0.7% |
| Q1 FY2024 | Mar 31, 2024 | $28.57M | -13.1% |
| Q4 FY2023 | Dec 31, 2023 | $27.87M | -11.0% |
| Q3 FY2023 | Sep 30, 2023 | $31.49M | +1.3% |
| Q2 FY2023 | Jun 30, 2023 | $28.44M | +3.3% |
| Q1 FY2023 | Mar 31, 2023 | $32.87M | +7.2% |
| Q4 FY2022 | Dec 31, 2022 | $31.32M | -22.0% |
| Q3 FY2022 | Sep 30, 2022 | $31.10M | +10.2% |
| Q2 FY2022 | Jun 30, 2022 | $27.52M | -4.3% |
| Q1 FY2022 | Mar 31, 2022 | $30.66M | -6.8% |
| Q4 FY2021 | Dec 31, 2021 | $40.16M | +47.6% |
| Q3 FY2021 | Sep 30, 2021 | $28.22M | +89.3% |
| Q2 FY2021 | Jun 30, 2021 | $28.77M | +213.3% |
| Q4 FY2020 | Dec 31, 2020 | $32.90M | +209.1% |
| Q3 FY2020 | Sep 30, 2020 | $27.21M | +168.2% |
| Q2 FY2020 | Jun 30, 2020 | $14.91M | +1.4% |
| Q1 FY2020 | Mar 31, 2020 | $9.18M | -62.5% |
| Q4 FY2019 | Dec 31, 2019 | $10.64M | -56.9% |
| Q3 FY2019 | Sep 30, 2019 | $10.15M | -78.1% |
| Q2 FY2019 | Jun 30, 2019 | $14.70M | -69.7% |
| Q1 FY2019 | Mar 31, 2019 | $24.47M | -50.8% |
| Q4 FY2018 | Dec 31, 2018 | $24.67M | -49.6% |
| Q3 FY2018 | Sep 30, 2018 | $46.33M | -6.9% |
| Q2 FY2018 | Jun 30, 2018 | $48.48M | -8.4% |
| Q1 FY2018 | Mar 31, 2018 | $49.78M | +1.7% |
| Q4 FY2017 | Dec 31, 2017 | $48.91M | -5.2% |
| Q3 FY2017 | Sep 30, 2017 | $49.75M | -20.1% |
| Q4 FY2016 | Dec 31, 2016 | $52.91M | -25.3% |
| Q3 FY2016 | Sep 30, 2016 | $48.94M | – |
| Q2 FY2016 | Jun 30, 2016 | $51.61M | – |
| Q1 FY2016 | Mar 31, 2016 | $62.23M | – |
| Q4 FY2015 | Dec 31, 2015 | $70.80M | – |
See a number that looks wrong?